Resistance to alpha interferon therapy in HCV chronic liver disease: role of hepatic fibrosis.

Di Costanzo, G G; Ascione, A; Lanza, A G; De Luca, M; Bracco, A; Lojodice, D; Marsilia, G M; Ferbo, U

Di Costanzo, G G; Ascione, A; Lanza, A G; De Luca, M; Bracco, A; Lojodice, D; Marsilia, G M; Ferbo, U.

Affiliation

Di Costanzo GG; Divisione di Fisiopatologia Epatica, Ospedale Cardarelli, Napoli, Italy.

Ital J Gastroenterol ; 28(3): 140-6, 1996 Apr.

Article in En | MEDLINE | ID: mdl-8789824

Subject(s)

Antiviral Agents/therapeutic use; Biomarkers/blood; Hepatitis C/therapy; Hepatitis, Chronic/therapy; Interferon-alpha/therapeutic use; Laminin/blood; Liver Cirrhosis/pathology; Peptide Fragments/blood; Procollagen/blood; Biopsy; Female; Hepatitis C/blood; Hepatitis C/diagnosis; Hepatitis, Chronic/blood; Hepatitis, Chronic/diagnosis; Humans; Interferon alpha-2; Liver/pathology; Male; Middle Aged; Predictive Value of Tests; Recombinant Proteins; Regression Analysis; Sensitivity and Specificity

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Antiviral Agents / Peptide Fragments / Biomarkers / Laminin / Procollagen / Interferon-alpha / Hepatitis C / Hepatitis, Chronic / Liver Cirrhosis Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Ital J Gastroenterol Year: 1996 Document type: Article

Search on Google

XML

PubMed Links